Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While GHRP-6 is used experimentally to produce strong GH surges and hyperphagia, allowing investigation of GH-dependent anabolism and energy-balance regulation2030, Setmelanotide is approved for chronic weight management in patients with POMC, PCSK1, LEPR deficiencies and Bardet–Biedl syndrome by reducing hunger and promoting weight loss92.
While GHRP-6 works as a first-generation synthetic hexapeptide ghrelin mimetic that potently stimulates GH release and markedly increases appetite via GHSR-1a activation in hypothalamus and pituitary203096, Setmelanotide is a potent synthetic melanocortin-4 receptor (MC4R) agonist derived from a POMC/α-MSH–related sequence that restores downstream MC4R signaling in genetic obesity syndromes3192100.
GHRP-6
GHSR
Setmelanotide
POMC
The clearest overlap between GHRP-6 and Setmelanotide is that both converge around Receptor agonist. Both are often discussed in Metabolic and endocrine contexts, while GHRP-6 is more of a hormone peptide and Setmelanotide is better described as a metabolic peptide and Neuropeptide. Both appear to work through Receptor agonist, but the functional emphasis still separates, with GHRP-6 leaning toward Anabolic growth and Setmelanotide leaning toward Metabolic regulation. Both are synthetic in origin and their development context also differs, with GHRP-6 in Preclinical development while Setmelanotide is approved. GHRP-6 takes the form of a linear peptide, whereas Setmelanotide is closer to a cyclic peptide.
No related articles are linked to these peptides yet.